TODAY'S HEADLINES

FDA warns about OTC antacids, antidiarrheal med

FDA is warning consumers about the risk of serious bleeding when using over-the-counter aspirin-containing antacid products to treat heartburn. The agency also issued a separate warning about loperamide (Imodium), saying that abuse of the product can cause serious heart problems that can lead to death. Read more

New hypertension drug gets FDA approval

The first and only fixed-dose combination of a beta blocker (BB) and angiotensin II receptor blocker (ARB) for hypertension will be available soon. Read more

CONTINUING PHARMACY EDUCATION

The rundown: Management of acute and chronic diarrhea

This month's CE activity, "The rundown: Management of acute and chronic diarrhea," is open for pharmacists and pharmacy technicians.
The goal of this activity is to review the various risk factors, etiologies, and treatments of diarrhea as well as the pharmacist's role in its management.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Why new bladder cancer drug is novel

FDA recently granted accelerated approval for atezolizumab (Tecentriq) for people with locally advanced or metastatic urothelial carcinoma (mUC). How it's unique

June 10, 2016

Related Articles

FDA warns about Cipro, other antibacterials

Major diabetes drug cuts heart attack risk